Helicobacter pylori: good side complicates efforts to combat bad side.
McNeil
Caroline
C
D000230:Adenocarcinoma / Q000453:epidemiology* / Q000517:prevention & control; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001211:Asia, Western / Q000453:epidemiology; D001249:Asthma / Q000453:epidemiology* / Q000517:prevention & control; D014408:Biomarkers, Tumor; D024881:Drug Resistance, Bacterial; D004938:Esophageal Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D005202:Asia, Eastern / Q000453:epidemiology; D006291:Health Policy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008403:Mass Screening; D011159:Population Surveillance; D018570:Risk Assessment; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D014944:World Health Organization
D000900:Anti-Bacterial Agents; D014408:Biomarkers, Tumor